Daniel Parras
Overview
Explore the profile of Daniel Parras including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
248
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cranford H, Parras D, Jones P, Endemano E, Chung-Bridges K, Pinheiro P
J Racial Ethn Health Disparities
. 2025 Mar;
PMID: 40048081
Aim: Examine racial and ethnic inequities in hepatitis C and B virus (HCV and HBV) screening across high-risk populations. Subject And Methods: Chronic HCV and HBV infections can lead to...
2.
Gaimari A, De Lucia A, Nicolini F, Mazzotti L, Maltoni R, Rughi G, et al.
Int J Mol Sci
. 2024 Nov;
25(22).
PMID: 39596267
Recent times have witnessed remarkable progress in cancer immunotherapy, drastically changing the cancer treatment landscape. Among the various immunotherapeutic approaches, adoptive cell therapy (ACT), particularly chimeric antigen receptor (CAR) T...
3.
Christy S, Patel L, Arevalo M, Fuzzell L, Whitmer A, Turner K, et al.
Contemp Clin Trials
. 2024 May;
142:107576.
PMID: 38763306
Background: This protocol paper describes the overall design for HPV MISTICS, a multilevel intervention to increase human papillomavirus (HPV) vaccination initiation and completion rates among adolescents aged 11-17. Methods: We...
4.
Heintzman J, Hodes T, Parras D, Lucas J, Vasquez Guzman C, Chan B, et al.
Prev Med
. 2023 Aug;
175:107657.
PMID: 37573954
Introduction: Latinas in the United States have higher mortality from breast cancer, but longitudinal studies of mammography ordering (a crucial initial step towards screening) in primary care are lacking. Methods:...
5.
Nasir M, Cook N, Parras D, Mukherjee S, Miller G, Ferres J, et al.
J Health Care Poor Underserved
. 2023 Jul;
34(2):521-534.
PMID: 37464515
Understanding how post-acute COVID-19 syndrome (PACS or long COVID) manifests among underserved populations, who experienced a disproportionate burden of acute COVID-19, can help providers and policymakers better address this ongoing...
6.
Sole P, Parras D, Yamanouchi J, Garnica J, Garabatos N, Moro J, et al.
Front Immunol
. 2023 May;
14:1177722.
PMID: 37153608
Systemic delivery of nanoparticles (NPs) coated with mono-specific autoimmune disease-relevant peptide-major histocompatibility complex class II (pMHCII) molecules can resolve organ inflammation in various disease models in a disease-specific manner without...
7.
Kogevinas M, Karachaliou M, Espinosa A, Aguilar R, Castano-Vinyals G, Garcia-Aymerich J, et al.
Environ Health Perspect
. 2023 Apr;
131(4):47001.
PMID: 37017430
Background: Ambient air pollution has been associated with COVID-19 disease severity and antibody response induced by infection. Objectives: We examined the association between long-term exposure to air pollution and vaccine-induced...
8.
Horigian V, Schmidt R, Duan R, Parras D, Chung-Bridges K, Batycki J, et al.
Front Public Health
. 2023 Apr;
11:1122455.
PMID: 37006591
Introduction: Patients with diabetes and comorbid substance use disorders (SUD) experience poor diabetes management, increased medical complications and mortality. However, research has documented that patients engaged in substance abuse treatment...
9.
Rubio R, Aguilar R, Bustamante M, Munoz E, Vazquez-Santiago M, Santano R, et al.
Front Immunol
. 2022 Oct;
13:999136.
PMID: 36238312
SARS-CoV-2 infected pregnant women are at increased risk of severe COVID-19 than non-pregnant women and have a higher risk of adverse pregnancy outcomes like intrauterine/fetal distress and preterm birth. However,...
10.
Karachaliou M, Moncunill G, Espinosa A, Castano-Vinyals G, Rubio R, Vidal M, et al.
BMC Med
. 2022 Sep;
20(1):347.
PMID: 36109713
Background: Heterogeneity of the population in relation to infection, COVID-19 vaccination, and host characteristics is likely reflected in the underlying SARS-CoV-2 antibody responses. Methods: We measured IgM, IgA, and IgG...